Diagnosis, Prevalence, Awareness, Treatment, Prevention, and Control of Hypertension in Cameroon: Protocol for a Systematic Review and Meta-Analysis of Clinic-Based and Community-Based Studies
暂无分享,去创建一个
A. Kengne | B. Kuate Defo | E. Sobngwi | L. Potvin | J. Tardif | R. Weladji | L. Richard | M. Dubé | F. Assah | J. Mbanya | S. de Denus | R. Cote | P. Fournier | D. Todem | L. Cloutier | Roxane Borgès da Silva | C. Dagenais | C. Dubois | K. Frohlich | S. Choukem | Roland Pongou | V. Ridde | E. Rey | D. Nsagha | S. Perreault | L. Monnais | Z. Njoumemi | O. Ekundayo | C. Zarowsky | W. Mbacham | S. Kingue | A. Tanya | L. Roy | W. Mampuya | A. Dzudie | E. Emami | M. Hatem | J. Lafrance | D. Mbanya | P. Ndom | J. Saji
[1] D. Lackland,et al. Implementing standardized performance indicators to improve hypertension control at both the population and healthcare organization levels , 2017, Journal of clinical hypertension.
[2] Ivy Shiue,et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015 , 2017, JAMA.
[3] Hynek Pikhart,et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants , 2017, The Lancet.
[4] S. Yusuf,et al. Social disparities explain differences in hypertension prevalence, detection and control in Colombia , 2016, Journal of hypertension.
[5] C. Toniolo,et al. Nutritional composition, bioactive compounds and volatile profile of cocoa beans from different regions of Cameroon , 2016, International journal of food sciences and nutrition.
[6] R. Walker,et al. Hypertension in Sub-Saharan Africa; prevalence, prescriptions, pitfalls and paradigms , 2016, Journal of Human Hypertension.
[7] F. Cappuccio,et al. Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions , 2016, Internal and Emergency Medicine.
[8] M. Woodward,et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis , 2016, The Lancet.
[9] W. Aronow,et al. Hypertension in Sub-Saharan Africa: A Contextual View of Patterns of Disease, Best Management, and Systems Issues , 2016, Cardiology in review.
[10] O. Uthman,et al. Prevalence of Hypertension in Low- and Middle-Income Countries , 2015, Medicine.
[11] Dan J Stein,et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, BDJ.
[12] M. Olsen,et al. A global perspective on hypertension: a Lancet Commission , 2015, The Lancet.
[13] S. Yusuf,et al. Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approach , 2015, BMC Health Services Research.
[14] N. Campbell,et al. Hypertension in sub-Saharan Africa: a massive and increasing health disaster awaiting solution , 2015, Cardiovascular journal of Africa.
[15] K. S. Bobo,et al. Wildlife use and the role of taboos in the conservation of wildlife around the Nkwende Hills Forest Reserve; South-west Cameroon , 2015, Journal of Ethnobiology and Ethnomedicine.
[16] G. Parati,et al. Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk – overview and meta-analyses of randomized trials , 2014, Journal of hypertension.
[17] Hilary K. Wall,et al. Patients with undiagnosed hypertension: hiding in plain sight. , 2014, JAMA.
[18] Tej K. Khalsa,et al. Standards for the Uniform Reporting of Hypertension in Adults Using Population Survey Data: Recommendations From the World Hypertension League Expert Committee , 2014, Journal of clinical hypertension.
[19] A. Thrift,et al. Do the socioeconomic and hypertension gradients in rural populations of low- and middle-income countries differ by geographical region? A systematic review and meta-analysis. , 2014, International journal of epidemiology.
[20] L. Fourcade,et al. [Sociocultural and medical management of hypertension in sub-Saharan Africa]. , 2014, Medecine et sante tropicales.
[21] Huguette Gaelle Ngassa Mbenda,et al. Does malaria epidemiology project Cameroon as ‘Africa in miniature’? , 2014, Journal of Biosciences.
[22] R. Townsend,et al. Top 10 landmark studies in hypertension. , 2014, Journal of the American Society of Hypertension : JASH.
[23] B. K. Defo. Beyond the ‘transition’ frameworks: the cross-continuum of health, disease and mortality framework , 2014, Global health action.
[24] B. K. Defo. Demographic, epidemiological, and health transitions: are they relevant to population health patterns in Africa? , 2014, Global health action.
[25] Martin McKee,et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. , 2013, JAMA.
[26] B. Rayner,et al. Recent advances in hypertension in sub-Saharan Africa , 2013, Heart.
[27] Stephen S. Lim,et al. Prevalence, Awareness, Treatment, and Control of Hypertension in United States Counties, 2001–2009 , 2013, PloS one.
[28] S. Manda,et al. Geographic variation of hypertension in sub-saharan Africa: a case study of South Africa. , 2013, American journal of hypertension.
[29] K. Lange,et al. Genetics of early-onset obsessive–compulsive disorder , 2010, European Child & Adolescent Psychiatry.
[30] B. Balkau,et al. Ten-year change in blood pressure levels and prevalence of hypertension in urban and rural Cameroon , 2009, Journal of Epidemiology & Community Health.
[31] D. Beevers,et al. Hypertension in ethnic groups: epidemiological and clinical perspectives , 2009, Expert review of cardiovascular therapy.
[32] N. Lunet,et al. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries , 2009, Journal of hypertension.
[33] H. Yatsuya,et al. Self-reported medical history was generally accurate among Japanese workplace population. , 2009, Journal of clinical epidemiology.
[34] Li-sheng Liu,et al. Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.
[35] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[36] G. Salem,et al. Hypertension, urbanization, social and spatial disparities: a cross-sectional population-based survey in a West African urban environment (Ouagadougou, Burkina Faso). , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[37] J. Zicha,et al. Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view. , 2006, Clinical science.
[38] Lisa Hartling,et al. Single data extraction generated more errors than double data extraction in systematic reviews. , 2006, Journal of clinical epidemiology.
[39] I. Hajjar,et al. Hypertension: trends in prevalence, incidence, and control. , 2006, Annual review of public health.
[40] P. Sorlie,et al. The Burden of Adult Hypertension in the United States 1999 to 2000: A Rising Tide , 2004, Hypertension.
[41] Douglas W Mahoney,et al. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. , 2004, Journal of clinical epidemiology.
[42] Erik von Elm,et al. Different patterns of duplicate publication: an analysis of articles used in systematic reviews. , 2004, JAMA.
[43] M. Porta. Textbook of cancer epidemiology , 2003 .
[44] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[45] J. Eriksson,et al. Fetal origins of adult disease: strength of effects and biological basis. , 2002, International journal of epidemiology.
[46] L. Hansson. Hypertension management in 2002: where have we been? where might we be going? , 2002, American journal of hypertension.
[47] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[48] Y. Ben-Shlomo,et al. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. , 2002, International journal of epidemiology.
[49] S. Yusuf,et al. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. , 2001, Circulation.
[50] C. Navarro,et al. Validation of self diagnosis of high blood pressure in a sample of the Spanish EPIC cohort: overall agreement and predictive values , 2000, Journal of epidemiology and community health.
[51] N. Black,et al. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. , 1998, Journal of epidemiology and community health.
[52] N. Poulter,et al. Socio-economic status and blood pressure: an overview analysis , 1998, Journal of Human Hypertension.
[53] Jan A Staessen,et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.
[54] M. Tramèr,et al. Impact of covert duplicate publication on meta-analysis: a case study , 1997, BMJ.
[55] M Susser,et al. Choosing a future for epidemiology: II. From black box to Chinese boxes and eco-epidemiology. , 1996, American journal of public health.
[56] B. K. Defo. Areal and socioeconomic differentials in infant and child mortality in Cameroon. , 1996, Social science & medicine.
[57] P Whelton,et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.
[58] O Lewis,et al. Stephen Hales and the measurement of blood pressure. , 1994, Journal of human hypertension.
[59] M. C. Leske,et al. Comparing self-reported and physician-reported medical history. , 1994, American journal of epidemiology.
[60] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[61] M. Crawford. Nutritional Control of Heart Disease and Cancer: Are Different Diets Necessary* , 1985, Nutrition and health.
[62] Ashutosh Kumar Singh,et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.
[63] L. Bortel,et al. Management of hypertension at the community level in Sub-Saharan Africa (SSA): towards a rational use of available resources , 2011, Journal of Human Hypertension.
[64] S. Syme,et al. Environments, people, and health. , 1983, Annual review of public health.